{"id":2707,"date":"2022-06-29T06:30:00","date_gmt":"2022-06-29T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/conference-call-on-interim-report-5\/"},"modified":"2022-06-29T06:30:00","modified_gmt":"2022-06-29T06:30:00","slug":"conference-call-on-interim-report-5","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/","title":{"rendered":"Conference call on Interim Report"},"content":{"rendered":"
\n

Invitation to attend XVIVO\u2019s conference call regarding the presentation of the interim report January-June 2022. The presentation will be held in English.<\/strong><\/p>\n<\/div>\n

\n

Time: Wednesday, July 13 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https:\/\/onlinexperiences.com\/Launch\/QReg\/ShowUUID=3B5B0C20-D56D-45E1-925D-4EE0B1B472D9<\/a><\/p>\n

Phone numbers to the conference:
Sweden: +46 856642651 PIN: 64438341#
UK: +44 3333000804 PIN: 64438341#
US: +1 6319131422 PIN: 64438341#
Conference name: XVIVO Interim Report Q2 2022
\u00a0
Participants from XVIVO:
Dag Andersson, CEO
Kristoffer Nordstr\u00f6m, CFO
\u00a0
The press release for XVIVO\u2019s interim report January-June 2022 will be released on July 13, 2022 at 7:30 a.m. CET.
\u00a0
Before the conference call, slides will be available at the company web page,\u00a0\u00a0https:\/\/www.xvivoperfusion.com\/corporate\/financial-presentations\/earnings-calls\/<\/a>\u00a0<\/p>\n

June 29, 2022
Gothenburg
XVIVO Perfusion AB (publ)<\/p>\n<\/div>\n

\n

For further information, please contact:<\/strong><\/p>\n\n

Dag Andersson, CEO, +46 76 643 30 31, e-mail:\u00a0dag.andersson@xvivogroup.com
Kristoffer\u00a0Nordstr\u00f6m, CFO, +46 73 519 21 64, e-mail:\u00a0kristoffer.nordstrom@xvivogroup.com<\/p>\n<\/div>\n

\n

About Us<\/strong><\/p>\n\n

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com\/us.<\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n\n

Conference call on Interim Report<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Invitation to attend XVIVO\u2019s conference call regarding the presentation of the interim report January-June 2022. The presentation will be held…<\/p>\n","protected":false},"template":"","class_list":["post-2707","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn"],"acf":[],"yoast_head":"\nConference call on Interim Report - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conference call on Interim Report - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Invitation to attend XVIVO\u2019s conference call regarding the presentation of the interim report January-June 2022. The presentation will be held...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-5\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-5\\\/\",\"name\":\"Conference call on Interim Report - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2022-06-29T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-5\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/conference-call-on-interim-report-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Conference call on Interim Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conference call on Interim Report - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/","og_locale":"en_US","og_type":"article","og_title":"Conference call on Interim Report - XVIVO","og_description":"Invitation to attend XVIVO\u2019s conference call regarding the presentation of the interim report January-June 2022. The presentation will be held...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/","name":"Conference call on Interim Report - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2022-06-29T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/conference-call-on-interim-report-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"Conference call on Interim Report"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}